Skip to main content
Premium Trial:

Request an Annual Quote

Luminex, Bio-Rad Extend Deal, Includes Magpix System

NEW YORK (GenomeWeb News) – Luminex today announced the expansion of a global sales and distribution deal with Bio-Rad Laboratories to 2023 as well as the granting of the global sales and distribution rights for the Magpix multiplexing platform.

Under the terms of the agreement Bio-Rad will offer Luminex's xMAP systems, including the Magpix system, which detects up to 50 different analytes on a single sample.

"As a leader in the life science research market, Bio-Rad can provide researchers additional access for this highly innovative instrument that offers a broad range of applications," Michael Pintek, senior vice president of operations at Luminex, said in a statement. "Together we can accelerate the pace of research and advance healthcare for people around the world."

Financial and other terms were not disclosed.